Lesson plan

Temocillin

Temocillin is a β-lactamase-resistant penicillin introduced by Beecham, marketed by Eumedica Pharmaceuticals as Negaban in Belgium, France, The Netherlands, Luxemburg, Sweden, Spain, United Kingdom and Ireland; and as Temopen in Germany. It is used primarily for the treatment of multiple drug-resistant, Gram-negative bacteria. It is actually a 6-methoxy Ticarcillin; it is also a carboxypenicillin.

Back to article

Article summary

Temocillin is a β-lactamase-resistant penicillin introduced by Beecham, marketed by Eumedica Pharmaceuticals as Negaban in Belgium, France, The Netherlands, Luxemburg, Sweden, Spain, United Kingdom and Ireland; and as Temopen in Germany. It is used primarily for the treatment of multiple drug-resistant, Gram-negative bacteria. It is actually a 6-methoxy Ticarcillin; it is also a carboxypenicillin.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.